Joseph Petrosino

Joseph Petrosino

@JosephPetrosino

Followers221
Following106

Chair, Dept of Molecular Virology and Microbiology; Dir, Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine; Opinions are my own

Houston, TX
Joined on January 31, 2020
@JosephPetrosino Statistics

We looked inside some of the tweets by @JosephPetrosino and found useful information for you.

Inside 100 Tweets

Time between tweets:
6 hours
Average replies
1
Average retweets
1
Average likes
3
Tweets with photos
0 / 100
Tweets with videos
0 / 100
Tweets with links
0 / 100
Fun Fact

69% of follows on Twitter are suggested by friends.

People sometimes ask me why the vaccine rollout hasn’t been as effective as it needs to be. There’s a list of reasons, but this article captures a significant part of the problem. https://t.co/I17UOJCG0D

0
0
0

Quoted @copperleaves3

@Reuters @LaurenYoung @CarolineHumer #AskReuters How do these vaccines affect those whose immunities are in a state of overdrive, such as in refractory autoimmune disorders?

.@copperleaves3 People with hyper-active immune responses/severe allergies, are one category where the CDC/others have issued words of caution. If you have access to a clinician, it would be advisable to speak to them. If not, I would wait for more data before being vaccinated https://t.co/xNfdqVN9Fq

1
0
1

Quoted @dorianjharris

@JosephPetrosino Thank you. To be clear, there is data which shows that #b117 is as severe or there’s no data to show either way as yet? Could it be less severe?

.@dorianjharris I haven't seen data suggesting one way or the other but, intuitively from what we know about the COVID related disease course and from hospitalizations, I would say that it it does not cause less severe outcomes at this time. https://t.co/oAeQcmppNJ

0
0
1

Quoted @dorianjharris

#AskReuters Is there any data on the severity of #b1117?

.@dorianjharris to date, the data suggest that #b1117 is more easily transmitted but doesn't not cause more severe disease. Masks, distancing, handwashing etc all still are good measures to reduce the risk of infection by this variant. #AskReuters https://t.co/nyGccYNTTU

1
0
1

Quoted @Radarmc2021

When will the oxford vaccine become available? And how many vaccinations will be required? #AskReuters

.@Radarmc2021 The AstraZeneca/Oxford vaccine was approved for EUA on Dec 30th. It requires two doses 4-12 weeks apart. #AskReuters https://t.co/HJiJH04YrS

0
0
1

Quoted @DrivesMac

#AskReuters Q, The vaccine does not stop you catching or spreading covid-19. True or false?

.@DrivesMac True for now. More data are needed to show whether or not vaccinated people can still carry the virus asymptomatically. For that reason, people who have been vaccinated should still wear masks, etc. for now. #AskReuters https://t.co/kPLB38bVKT

1
1
0

Quoted @KevGoodchild

Do people who have had #Covid build immunity? If so should the known number be added to the amount of people who have been vaccinated to give a more positive outlook? #AskReuters

.@KevGoodchild People have very different responses to COVID. Some have minimal signs of long term protection following infection. We need to learn what a truly protective immune response looks like. Until then, we cannot assume everyone who had #COVID is protected. #AskReuters https://t.co/n6ZwWuVLTR

1
0
1

Quoted @indylana

#AskReuters #askreutersif you've had covid and get the vaccine does that improve your odds of not contracting it?

.@indylana Yes, it will likely extend the immunity you may have after recovering from COVID. It may also fortify/strengthen your immune response to future exposures as well.#AskReuters https://t.co/OufzuNnMxo

1
0
1

Quoted @GilmerHealthLaw

@JosephPetrosino Agree. Chronic underfunding for decades has been a huge issue. As we work on funding now (hopefully. And recognizing it'll still not be enough) what do you think we can do in the meantime to address patients' need for info?

That's the question being wrestled with daily. Direct access is a priority. The science needs to be communicated effectively. During the pandemic, experts appear routinely on various media outlets-this is needed at a community level, at places where there is equal access to info. https://t.co/ea957W17vq

0
0
3

Quoted @GilmerHealthLaw

@Baba_Lilith @JosephPetrosino So the question becomes how do we get high quality info to patients (not just drs) so they can be engaged in their care? How do we connect pts like you with experts who may have more info recognizing you're doing the heavy lifting to care for yourself in an inadequate system?

Cannot underscore this point enough. Community awareness and communication is something we discuss constantly (even before COVID). Public health depts are underfunded and don't have the resources to provide the best and latest for many diseases. It requires a systemic overhaul. https://t.co/VwEDM1LrAg

1
1
4

Unfortunately, I've heard many stories like this... rheumatoid diseases can be difficult to diagnose. While more safety data are needed, based on how they work, and unless you have a known allergy to one of the vaccine components, you should be fine with either mRNA vaccine. https://t.co/KpS1sGsFfi

1
0
1

Quoted @GilmerHealthLaw

@Baba_Lilith @JosephPetrosino The problem is the assumption in access to care. Access to a clinic doesn't automatically equal access to high quality information. Some have no clinics to turn to (esp if they lost a job or live in a place where medicaid wasn't expanded or are in rural areas, etc).

Exactly, which is why we desperately need to fix healthcare in the U.S. A universal solution will SAVE taxpayers and improve quality of life. Disparities in access and coverage are just emphasized in times of crisis, such as the pandemic. Couldn't agree more. https://t.co/YF4yvL1seV

1
1
2

Quoted @Reuters

Thanks so much for joining today's #AskReuters chat! For more COVID-19 news, subscribe to our newsletter: https://t.co/t4HUXMqGpf https://t.co/bCmdseBGgc

Thanks so much for joining today's #AskReuters chat! For more COVID-19 news, subscribe to our newsletter: https://t.co/t4HUXMqGpf https://t.co/bCmdseBGgc

Thank you for hosting the discussion on these important topics! #AskReuters https://t.co/n1Cshq7P7T

Quoted @JosephPetrosino

.@Baba_Lilith @GlimerHealthLaw so the proper amount of funding and attention are given to these issues. Same goes for pregnant and nursing women. 2/2 https://t.co/Mi3DPIZH61

.@Baba_Lilith @GlimerHealthLaw Erin is right. Especially when developing/testing vaccines at "warp speed", it's difficult to conduct trials that examine enough individuals with prior health conditions to provide safety guidelines. These challenges NEED to be highlighted.1/2 https://t.co/MBx27SMbYG

0
0
0

.@Baba_Lilith @GlimerHealthLaw so the proper amount of funding and attention are given to these issues. Same goes for pregnant and nursing women. 2/2 https://t.co/Mi3DPIZH61

0
0
0

Quoted @LaurenYoung

Q9. What gives you hope now? #AskReuters https://t.co/eB26fkDGxh

Q9. What gives you hope now? #AskReuters https://t.co/eB26fkDGxh

A9. The efficacy and speed of development of several vaccines for #COVID one year after its emergence shows how much can be accomplished in a short time frame. This provides hope for responses to future vaccine-resistant #COVID strains and other future pandemics. #AskReuters https://t.co/5Ot48W0W5b

Quoted @JosephPetrosino

A8. @CarolineHumer CDC indicates that more data are needed, but the mRNA vaccines are unlikely to cause complications for those who are pregnant. I have seen/heard/know several pregnant women who have been vaccinated without complications to this point.#AskReuters https://t.co/8LeUw3hf4Y

A8.2 @CarolineHumer Questions around pregnancy underscores the need for more consideration/discussion of the enrollment of pregnant women in these trials (and better vaccine models to study their impact). The disease can be worse than side-effects from vaccination.#AskReuters https://t.co/IY8uVQxEj9

1
0
1

Quoted @CarolineHumer

Q8. What do we know about the vaccine's effects on pregnancy and reproductive health? #AskReuters

A8. @CarolineHumer CDC indicates that more data are needed, but the mRNA vaccines are unlikely to cause complications for those who are pregnant. I have seen/heard/know several pregnant women who have been vaccinated without complications to this point.#AskReuters https://t.co/8LeUw3hf4Y

1
2
3

Quoted @AlisonSbrana

@Reuters What is the current recommendation for vaccination of #LongCovid patients who still experience symptoms? Is there a minimum amount of time after infection patients need to wait before vaccinating? We’ve been getting lots of ?’s in @itsbodypolitic on this topic. #AskReuters

.@AlisonSbrana More data is needed. Current recommendations are to wait >90 days after the first infection. If the symptoms relate to the immune response (eg. pneumonia) then waiting 90 days after those primary symptoms subside would seem appropriate. #AskReuters https://t.co/TvTFE3jswZ

1
18
26

Quoted @LaurenYoung

Q7. Can you discuss the importance of vaccine access, particularly in lower-income countries? #AskReuters https://t.co/HKctBC0nWh

Q7. Can you discuss the importance of vaccine access, particularly in lower-income countries? #AskReuters https://t.co/HKctBC0nWh

A7. Vaccine access is tremendously important as we consider what is needed for global herd immunity. Inexpensive, rapidly produced, easily stored, and of course effective vaccines are needed. The @PeterHotez BiologicalE/Baylor vaccine is an example in trial in India. #AskReuters https://t.co/lzosGnkZW7

Next Page